Dysregulation of GdA Expression in Endometrium of Women With Endometriosis: Implication for Endometrial Receptivity

other OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by gemini-2.5-flash-lite, 2026-06-09

Glycodelin-A expression and glycoform profile are altered in the eutopic endometrium of women with endometriosis, potentially impacting endometrial receptivity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-09 · read from full text

The study evaluated glycodelin-A (GdA) expression in endometrial tissue from women with endometriosis and from women with proven fertility, sampling eutopic endometrium across different menstrual cycle phases and using immunolocalization and profiling of glycosylated glycoforms. GdA was synthesized by both endometrial epithelial and stromal cells, with a phase-dependent profile in healthy and endometriosis-associated eutopic endometrium, but during the secretory phase endometriotic eutopic endometrium showed a significant increase in GdA protein expression alongside a distinct glycoforms pattern. Protein localization in eutopic endometrium from women with endometriosis differed significantly from that of endometrium from proven fertile controls. The paper explicitly notes that the findings indicate altered GdA expression profiles in endometriosis, potentially linked to impaired endometrial receptivity. This paper is centrally about endometriosis — it characterizes dysregulated GdA expression and glycoform patterns in eutopic endometrium, relating these changes to endometrial receptivity.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Glycodelin-A (GdA) has been proposed to represent a potential biomarker of endometrial function, but little is known about its expression during the different phases of the menstrual cycle and under pathological conditions. In the light of its potential importance also in embryo implantation, we aimed to evaluate the expression profile of GdA as well as the presence of different glycosylated glycoforms and the immunolocalization in endometrial tissue from women with endometriosis and in women with proven fertility, at different times during the menstrual cycle. Our results showed that GdA is synthesized by endometrial epithelial and stromal cells, both in healthy endometrium and eutopic endometrium from women with endometriosis, with a profile including several glycosylated glycoforms, differentially expressed in each phase of the menstrual cycle. During the secretory phase, a significant increase in GdA protein expression, with a different glycoforms profile, was observed in endometriotic eutopic endometrium. Protein localization in eutopic endometrial tissue resulted significantly different in comparison with endometrium from women with proven fertility. This study indicate that GdA is a complex glycoprotein including up to 6 different glycoforms specifically expressed during the different phase of the menstrual cycle; in pathologic conditions such as endometriosis, the expression profile is altered possibly related to the impaired endometrial receptivity.
Full text 7,922 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Glycodelin-A (GdA) has been proposed to represent a potential biomarker of endometrial function, but little is known about its expression during the different phases of the menstrual cycle and under pathological conditions. In the light of its potential importance also in embryo implantation, we aimed to evaluate the expression profile of GdA as well as the presence of different glycosylated glycoforms and the immunolocalization in endometrial tissue from women with endometriosis and in women with proven fertility, at different times during the menstrual cycle. Our results showed that GdA is synthesized by endometrial epithelial and stromal cells, both in healthy endometrium and eutopic endometrium from women with endometriosis, with a profile including several glycosylated glycoforms, differentially expressed in each phase of the menstrual cycle. During the secretory phase, a significant increase in GdA protein expression, with a different glycoforms profile, was observed in endo-metriotic eutopic endometrium. Protein localization in eutopic endometrial tissue resulted significantly different in comparison with endometrium from women with proven fertility. This study indicate that GdA is a complex glycoprotein including up to 6 different glycoforms specifically expressed during the different phase of the menstrual cycle; in pathologic conditions such as endometriosis, the expression profile is altered possibly related to the impaired endometrial receptivity. Similar content being viewed by others

References

Vigano P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: epidemiology and aetiological factors. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):177–200. Barlow DH, Kennedy S. Endometriosis: new genetic approaches and therapy. Annu Rev Med. 2005;56:345–356. Gupta S, Ghulmiyyah J, Sharma R, Halabi J, Agarwal A. Power of proteomics in linking oxidative stress and female infertility. BiomedRes Int. 2014; Article ID 916212. Stratton P, Berkley KJ. Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications. Hum Reprod Update. 2011;17(3):327–346. Kao LC, Germeyer A, Tulac S, et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology. 2003;144(7):2870–2881. Vodolazkaia A, El-Aalamat Y, Popovic D, et al. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod. 2012;27(9):2698–2711. Kocbek V, Vouk K, Bersinger NA, Mueller MD, Lanisnik Rizner T. Panels of cytokines and other secretory proteins as potential biomarkers of ovarian endometriosis. J Mol Diagn. 2015;17(3):325–334. Seppala M, Koistinen H, Koistinen R. Glycodelins. Trends Endocrinol Metab. 2001;12(3):111–117. Okamoto N, Uchida A, Takakura K, et al. Suppression by human placental protein 14 of natural killer cell activity. Am J Reprod Immunol. 1991;26(4):137–142. Seppala M, Koistinen H, Koistinen R, Chiu PCN, Yeung WSB. Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations. Hum Reprod Update. 2007; 13(3):275–287. Lee CL, Lam KKW, Vijayan M, et al. The pleiotropic effect of glycodelin-A in early pregnancy. Am J Reprod Immunol. 2016; 75(3):290–297. Hempstock J, Cindrova-Davies T, Jauniaux E, Burton GJ. Endometrial glands as a source of nutrients, growth factors and cytokines during the first trimester of human pregnancy: a morphological and immunohistochemical study. Reprod Biol Endocrinol. 2004;2:58. Seppala M, Koistinen H, Koistinen R, Hautala L, Chiu PC, Yeimg WS. Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol. 2009;160(2):121–133. Mylonas I, Jeschke U, Kunert-Keil C, et al. Glycodelin A is expressed differentially in normal human endometrial tissue throughout the menstrual cycle as assessed by immunohistochemistry and in situ hybridization. Fertil Steril. 2006;86(5):1488–1497. Li TC, Ling E, Dalton C, Bolton AE, Cooke ID. Concentration of endometrial protein PP14 in uterine flushings throughout the menstrual cycle in normal, fertile women. Br J Obstet Gynaecol. 1993;100(5):460–464. Kao LC, Tulac S, Lobo S, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology. 2002;143(6):2119–2138. Drosdzol-Cop A, Skrzypulec-Plinta V. Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res. 2012;38(10):1245–1253. Kocbek V, Vouk K, Mueller MD, Rizner TL, Bersinger NA. Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis. Gynecol Endocrinol. 2013;29(5):455–459. Wei Q, St Clair JB, Fu T, Stratton P, Nieman LK. Reduced expression of biomarkers associated with the implantation window in women with endometriosis. Fertil Steril. 2009;91(5):1686–1691. Lee CL, Chiu PCN, Pang PC, et al. Glycosylation failure extends to glycoproteins in gestational diabetes mellitus: evidence from reduced α2–6 sialylation and impaired immunomodulatory activities of pregnancy-related glycodelin-A. Diabetes. 2011;60(3):909–917. Lee CL, Lam KK, Koistinen H, et al. Glycodelin-A as a paracrine regulator in early pregnancy. JReprodImmunol. 2011;90(1):29–34. American Fertility Society. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43(3):351–352. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72(7):248–254. Görg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis. 2000;21(6):1037–1053. Bjellqvist B, Pasquali C, Ravier F, Sanchez JC, Hochstrasser D. A nonlinear wide-range immobilized pH gradient for two-dimensional electrophoresis and its definition in a relevant pH scale. Electrophoresis. 1993;14(12):1357–1365. Laemmli UK, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680–685. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76(9):4350–4354. Carson DD, Farrar JD, Laidlaw J, Wright DA. Selective activation of the N-glycosylation apparatus in uteri by estrogen. J Biol Chem. 1990;265(5):2947–2955. Uchida H, Maruyama T, Ohta K, et al. Histone deacetylase inhibitor-induced glycodelin enhances the initial step of implantation. Hum Reprod. 2007;22(10):2615–2622. Wang P, Zhu L, Zhang X. The role of placental protein 14 in the pathogenesis of endometriosis. Reprod Sci. 2013;20(12):1465–1470. Gao J, Mazella J, Seppala M, Tseng L. Ligand activated hPR modulates the glycodelin promoter activity through the Spl sites in human endometrial adenocarcinoma cells. Mol Cell Endocrinol. 2001;176(1-2):97–102. Bruner-Tran KL, Herington JL, Duleba AJ, Taylor HS, Osteen KG. Medical management of endometriosis: emerging evidence linking inflammation to disease pathophysiology. Minerva Ginecol. 2013;65(2):199–213. Igarashi TM, Bruner-Tran KL, Yeaman GR, et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fertil Steril. 2005;84(1):67–74. Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Focarelli, R., Luddi, A., De Leo, V. et al. Dysregulation of GdA Expression in Endometrium of Women With Endometriosis: Implication for Endometrial Receptivity. Reprod. Sci. 25, 579–586 (2018). https://doi.org/10.1177/1933719117718276 Published: Version of record: Issue date: DOI: https://doi.org/10.1177/1933719117718276

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometrium Gene Expression Regulation Glycodelin Adult Endometriosis Endometrium Female Fertility Fertility Glycodelin Glycodelin Humans Menstrual Cycle Menstrual Cycle Young Adult

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-18T06:10:16.649438+00:00
pubmed
last seen: 2026-05-13T22:20:19.560968+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine